Evaluation of CAPTURER CMV Solid Phase Testing Over the Allowable Shelf-Life of Red Blood Cells (Adenine–Saline Added)

Kaariainen L, 1966, Increased levels of cytomegalovirus antibodies in an infectious mononucleosis-like syndrome after transfusion, British Medical Journal, 1, 1270, 10.1136/bmj.1.5498.1270 Hillyer, 1994, Methods for the reduction of transfusion-transmitted cytomegalovirus infection: filtration verses the use of seronegative donor units, Transfusion, 34, 929, 10.1046/j.1537-2995.1994.341095026982.x James, 1997, The presence of free infectious (CMV) in the plasma of donated CMV-seropositive blood and platelets, Transfusion Medicine, 7, 123, 10.1046/j.1365-3148.1997.d01-14.x Gunter KC, Luban NLC: Transfusion-transmitted cytomegalovirus and epstein-barr virus diseases, In Rossi EC, Simon TL, Moss GS, Gould SA (eds.): Principals of transfusion medicine, 2nd ed., Baltimore, Williams and Wilkins, 1996; 717–731. Prezepiorka, 1996, Prevention of transfusion-associated cytomegalovirus infection, practice parameter, Am J Clin Pathol, 106, 163, 10.1093/ajcp/106.2.163 Sayers, 1992, Reducing the risk for transfusion-transmitted cytomegalovirus infection, Annals of Internal Medicine, 116, 55, 10.7326/0003-4819-116-1-55 Riggert, 1997, Prestorage inline filtration of whole blood for obtaining white cell-reduced blood components, Transfusion, 37, 1039, 10.1046/j.1537-2995.1997.371098016442.x FDA blood panel finds fault with data suggesting that leukoreduction is equivalent to donor testing in preventing CMV, In Douglas S (ed.): AABB Weekly Report 9/19/1997; 5–9. Menitove JE et al. (eds.): AABB Standards 18th edn., Bethesda, MD, American Association of Blood Banks, 1997; 25–26. CAPTURER-CMV: Solid phase system for the detection of IgG and IgM antibodies to cytomegalovirus (package insert). Norcross, GA, Immucor, 1995.